Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
PGIM Global High Yield Fund, Inc Declares Dividend of $0.11 (NYSE:GHY)
PGIM Global High Yield Fund, Inc (NYSE:GHY – Get Free Report) announced a dividend on Saturday, December 7th,investing.com reports. Shareholders...
Financial Contrast: JFrog (NASDAQ:FROG) & CS Disco (NYSE:LAW)
JFrog (NASDAQ:FROG – Get Free Report) and CS Disco (NYSE:LAW – Get Free Report) are both computer and technology companies,...
PaperClip Incorporated Plans Dividend of $0.01 (OTC:PCPJ)
PaperClip Incorporated (OTC:PCPJ – Get Free Report) announced a dividend on Thursday, December 5th,NASDAQ Dividends reports. Shareholders of record on...
Cryptocurrencies Pose High Risk to 401(k) Portfolios, Government Watchdog Warns
By Naveen Athrappully Cryptocurrencies in 401(k) retirement accounts expose portfolios to high risk of decline, with the value of these...
SCOTUS Asked to Block State From Investigating Doctors Who Question COVID-19 Policies
By Matthew Vadum U.S. Supreme Court Justice Clarence Thomas this week revived an emergency application to block the Washington Medical...
Goldman Sachs Hedge Industry VIP ETF (NYSEARCA:GVIP) Share Price Crosses Above Fifty Day Moving Average – Should You Sell?
Goldman Sachs Hedge Industry VIP ETF (NYSEARCA:GVIP – Get Free Report) crossed above its 50 day moving average during trading...